Skip to the main content.
Request a Quote

Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio. Read the Press Release

At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Ali Yehia

Ali Yehia is the Chief Scientific Officer at Fluxion Biosciences.

2 min read

Models show a decrease in breast cancer metastasis when ion channels are modulated.

Existing pre-approved FDA drugs targeting potassium channels may help in Cancer treatment Electrical voltage patterns in healthy cells serve as a guide for a well-organized cell development process. The opposite occurs with cancer, though. Cells...

Read More

3 min read

The Many Modulators of Sleep

As we go through our lives, we spend a third of that time sleeping. Although this time does not amass to anything consciously productive, it is a...

Read More

2 min read

It's All in the Numbers! Predicting Unwanted Drug/Heart Interactions with Artificial Intelligence

It may be difficult to fathom, but that little device you carry in your pocket to play Candy Crush and read your social media feeds has enough...

Read More